Document Detail

High altitude exposure reduces bronchial responsiveness to hypo-osmolar aerosol in lowland asthmatics.
MedLine Citation:
PMID:  8620949     Owner:  NLM     Status:  MEDLINE    
It is well-known that many patients with asthma undergo clinical improvement during a stay at high altitude. At high altitude, the atmospheric and climatic conditions (such as hypoxia, cold and dry air inhalation) could modify the bronchial responsiveness in asthmatics. Our study was designed to assess the difference in bronchial responsiveness to hypotonic aerosol between sea level and high altitudes in nonresident asthmatic subjects. The results were obtained during two mountaineering expeditions above 4,000 m i.e. at 4,559 m on Mt Rosa, Italy; and at 5,050 m near the Mt Everest base camp in Nepal. Eleven mild asthmatics performed standard bronchial challenges with ultrasonically nebulized distilled water (5 min inhalation, delivery 2 mL-min-1) at sea level and after staying at least 72 h at the above mentioned altitudes. The decrease in forced expiratory volume in one second (FEV1) from baseline was used as index of bronchial response. There was no significant difference in pre-challenge FEV1 between sea level and high altitude in either study. However, the bronchoconstriction response to ultrasonically nebulized distilled water was significantly reduced at high altitude in both studies. At sea level the mean FEV1 decrease was 22.2% (range 15-35%), whereas as the maximal altitude it was 6.7% (range 2-11%). Our results indicate that there is a reduction in bronchial responsiveness to hypoosmolar aerosol at high altitude. This suggests that atmospheric and climatic conditions, or physiological adaptations, via mediators such as atrial natriuretic peptide, are beneficial to patients with asthma at high altitude.
L Allegra; A Cogo; D Legnani; P L Diano; V Fasano; G G Negretto
Related Documents :
10817139 - Serological analysis of a cryptosporidiosis epidemic.
21301509 - Predicting the exercise catastrophe in the post-coronary patient.
11745129 - Effects of furfural on anaerobic continuous cultivation of saccharomyces cerevisiae.
3586109 - Altitude and wind effects on long jump performance with particular reference to the wor...
9467759 - Cognitive inhibition in individuals prone to homophobia.
11821489 - Effect of menstrual cycle phase on exercise performance of high-altitude native women a...
17218889 - Related trends in locomotor and respiratory muscle oxygenation during exercise.
16977709 - Heart rate at lactate threshold and cycling time trials.
1773809 - The influence of dietary manipulation on plasma ammonia accumulation during incremental...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The European respiratory journal     Volume:  8     ISSN:  0903-1936     ISO Abbreviation:  Eur. Respir. J.     Publication Date:  1995 Nov 
Date Detail:
Created Date:  1996-06-14     Completed Date:  1996-06-14     Revised Date:  2013-05-23    
Medline Journal Info:
Nlm Unique ID:  8803460     Medline TA:  Eur Respir J     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  1842-6     Citation Subset:  IM    
Institute of Respiratory Diseases, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Asthma / physiopathology*
Bronchial Hyperreactivity / physiopathology*
Forced Expiratory Volume / drug effects
Hypotonic Solutions / administration & dosage,  pharmacology
Middle Aged
Water / administration & dosage,  pharmacology*
Reg. No./Substance:
0/Aerosols; 0/Hypotonic Solutions; 7732-18-5/Water

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro an...
Next Document:  Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.